RxDoctor Payments Data

Kelly Mixon, NP

Family · Thomasville, GANPI 1376121426

Payments from drug & device makers

$3,667in general payments, 2019–2025

Across 198 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$650
  • AstraZeneca$528
  • Merck$390
  • Boehringer Ingelheim$327
  • Amgen$322
  • E.r. Squibb & Sons, L.L.C.$306
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,667100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,667 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$13,871
Medicare patients
123
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol35$25,730
EliquisApixaban32$20,557
EntrestoSacubitril/Valsartan28$20,083
BrilintaTicagrelor17$8,666
Ranolazine ErRanolazine14$652
ClopidogrelClopidogrel Bisulfate27$334
Metoprolol Succinate37$286
Atorvastatin Calcium42$220
Ezetimibe14$193
Famotidine14$162
Losartan Potassium18$122
Metoprolol Tartrate22$91
Carvedilol18$85
Furosemide17$66
Potassium Chloride14$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$528$34,39652 claims
PfizerEliquis$258$20,55732 claims
NovartisEntresto$650$20,08328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.

Other family in Thomasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →